Concert Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Company Update
The Pharma Data
NOVEMBER 4, 2020
and Canada) or (484) 365-2865 (International) five minutes prior to the start time. License and research and development revenue. ET to provide an update on the Company and discuss third quarter financial results. To access the conference call, please dial (855) 354-1855 (U.S. 2019.
Let's personalize your content